Solitary Bone Plasmacytoma
2 clinical trials · Condition
◉ Watch Solitary Bone Plasmacytoma
| Record | Firm | Date |
|---|---|---|
| Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration (NCT07115667) | Institute of Hematology & Blood Diseases Hospital, China | 2025-08-25 |
| A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma (NCT03196401) | Memorial Sloan Kettering Cancer Center | 2017-07-27 |
Track Solitary Bone Plasmacytoma automatically
Every clearance here is in the API, with alerts when new ones post.